Nicholas M. Dean

9.7k total citations · 1 hit paper
99 papers, 7.8k citations indexed

About

Nicholas M. Dean is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nicholas M. Dean has authored 99 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 19 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Nicholas M. Dean's work include DNA and Nucleic Acid Chemistry (19 papers), Protein Kinase Regulation and GTPase Signaling (19 papers) and RNA Interference and Gene Delivery (18 papers). Nicholas M. Dean is often cited by papers focused on DNA and Nucleic Acid Chemistry (19 papers), Protein Kinase Regulation and GTPase Signaling (19 papers) and RNA Interference and Gene Delivery (18 papers). Nicholas M. Dean collaborates with scholars based in United States, Switzerland and United Kingdom. Nicholas M. Dean's co-authors include Robert A. McKay, C. Frank Bennett, Brett P. Monia, Seongjoon Koo, Eric G. Marcusson, Alton L. Boynton, Richard E. Honkanen, James D. Moyer, Richard H. Griffey and Timothy D. Hill and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Nicholas M. Dean

99 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-143 Regulates Adipocyte Differentiation

2004 831 citations Christine Esau, Xiaolin Kang et al. Journal of Biological Chemistry profile →

Peers

Nicholas M. Dean

ONCOL

IMMUN

Salvatore Oliviero Italy

Kevin D. Brown United States

Steven B. McMahon United States

Andrew D Sharrocks United Kingdom

Qiang Yu Singapore

Ralf Janknecht United States

Ross D. Hannan Australia

Jianjun Shen United States

Annalisa Pession Italy

Ningzhi Xu China

Salvatore Oliviero Italy

Nicholas M. Dean

5.3k ×0.9

1.2k ×0.8

1.2k ×1.1

ONCOL

479 ×0.8

670 ×1.2

IMMUN

Citations per year, relative to Nicholas M. Dean Nicholas M. Dean (= 1×) peers Salvatore Oliviero

Countries citing papers authored by Nicholas M. Dean

Since Specialization

Citations

This map shows the geographic impact of Nicholas M. Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas M. Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas M. Dean more than expected).

Fields of papers citing papers by Nicholas M. Dean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas M. Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas M. Dean. The network helps show where Nicholas M. Dean may publish in the future.

Co-authorship network of co-authors of Nicholas M. Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas M. Dean. A scholar is included among the top collaborators of Nicholas M. Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas M. Dean. Nicholas M. Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Musiyenko, Alla, Joel Andrews, Gudrun Urban, et al.. (2013). Suppression of Ser/Thr Phosphatase 4 (PP4C/ PPP4C ) Mimics a Novel Post-Mitotic Action of Fostriecin, Producing Mitotic Slippage Followed by Tetraploid Cell Death. Molecular Cancer Research. 11(8). 845–855. 12 indexed citations

Sisco, Mark, Zol Kryger, Kristina O’Shaughnessy, et al.. (2008). Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair and Regeneration. 16(5). 661–673. 73 indexed citations

Kim, Youngsoo, Joon Won Yoon, Xiaokun Xiao, et al.. (2007). Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells. Cancer Research. 67(8). 3583–3593. 91 indexed citations

Koller, Erich, Stephanie Propp, Hong Zhang, et al.. (2006). Use of a Chemically Modified Antisense Oligonucleotide Library to Identify and Validate Eg5 (Kinesin-Like 1) as a Target for Antineoplastic Drug Development. Cancer Research. 66(4). 2059–2066. 32 indexed citations

Vickers, Timothy A., Hong Zhang, Mark J. Graham, et al.. (2006). Modification of MyD88 mRNA Splicing and Inhibition of IL-1β Signaling in Cell Culture and in Mice with a 2′- O -Methoxyethyl-Modified Oligonucleotide. The Journal of Immunology. 176(6). 3652–3661. 40 indexed citations

Perera, Ranjan J., Seongjoon Koo, C. Frank Bennett, et al.. (2006). Defining the transcriptome of accelerated and replicatively senescent keratinocytes reveals links to differentiation, interferon signaling, and Notch related pathways. Journal of Cellular Biochemistry. 98(2). 394–408. 10 indexed citations

Gysin, Stephan, Sanghyun Lee, Nicholas M. Dean, & Martin McMahon. (2005). Pharmacologic Inhibition of RAF→MEK→ERK Signaling Elicits Pancreatic Cancer Cell Cycle Arrest Through Induced Expression of p27Kip1. Cancer Research. 65(11). 4870–4880. 122 indexed citations

Perera, Ranjan J., Eric G. Marcusson, Seongjoon Koo, et al.. (2005). Identification of novel PPARγ target genes in primary human adipocytes. Gene. 369. 90–99. 55 indexed citations

Esau, Christine, Xiaolin Kang, Eigen Peralta, et al.. (2004). MicroRNA-143 Regulates Adipocyte Differentiation. Journal of Biological Chemistry. 279(50). 52361–52365. 831 indexed citations breakdown →

10.

Cordeiro, M. Francesca, Anna Mead, Robin R. Ali, et al.. (2003). Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome. Gene Therapy. 10(1). 59–71. 149 indexed citations

11.

Chen, Zongyou, Lina Lü, Hong Zhang, et al.. (2003). Administration of antisense oligodeoxyribonucleotides targeting NF‐κB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 23(5). 494–497. 4 indexed citations

12.

Patel, Niketa, Duane C. Eichler, David Chappell, et al.. (2003). The Protein Kinase C βII Exon Confers mRNA Instability in the Presence of High Glucose Concentrations. Journal of Biological Chemistry. 278(2). 1149–1157. 11 indexed citations

13.

Urban, Gudrun, Teresa Golden, Ileana Aragon, et al.. (2001). Identification of an Estrogen-inducible Phosphatase (PP5) That Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-independent Phenotype when Expressed Constitutively. Journal of Biological Chemistry. 276(29). 27638–27646. 47 indexed citations

14.

Patel, Niketa, Charles E. Chalfant, James Watson, et al.. (2001). Insulin Regulates Alternative Splicing of Protein Kinase C βII through a Phosphatidylinositol 3-Kinase-dependent Pathway Involving the Nuclear Serine/Arginine-rich Splicing Factor, SRp40, in Skeletal Muscle Cells. Journal of Biological Chemistry. 276(25). 22648–22654. 68 indexed citations

15.

Karras, James G., Robert A. McKay, Scott Cooper, et al.. (2000). Inhibition of Antigen-Induced Eosinophilia and Late Phase Airway Hyperresponsiveness by an IL-5 Antisense Oligonucleotide in Mouse Models of Asthma. The Journal of Immunology. 164(10). 5409–5415. 55 indexed citations

16.

Flynn, Peter F., et al.. (2000). Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival. Current Biology. 10(22). 1439–1442. 73 indexed citations

17.

Karras, James G., Robert A. McKay, Tao Lü, Nicholas M. Dean, & Brett P. Monia. (2000). Antisense Inhibition of Membrane-Bound Human Interleukin-5 Receptor-α Chain Does Not Affect Soluble Receptor Expression and Induces Apoptosis in TF-1 Cells. Antisense and Nucleic Acid Drug Development. 10(5). 347–357. 4 indexed citations

18.

Bost, Frédéric, Robert A. McKay, Nicholas M. Dean, Olga Potapova, & Dan Mercola. (2000). [24] Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family. Methods in enzymology on CD-ROM/Methods in enzymology. 314. 342–362. 10 indexed citations

19.

Potapova, Olga, Myriam Gorospe, Frédéric Bost, et al.. (2000). c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells. Journal of Biological Chemistry. 275(32). 24767–24775. 90 indexed citations

20.

Marcusson, Eric G., Bruce Yacyshyn, William Shanahan, & Nicholas M. Dean. (1999). Preclinical and Clinical Pharmacology of Antisense Oligonucleotides. Molecular Biotechnology. 12(1). 1–12. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact